<VariationArchive VariationID="1071657" VariationName="NM_000158.4(GBE1):c.216del (p.Tyr73fs)" VariationType="Deletion" Accession="VCV001071657" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2021-05-10" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1059901" VariationID="1071657">
      <GeneList>
        <Gene Symbol="GBE1" FullName="1,4-alpha-glucan branching enzyme 1" GeneID="2632" HGNC_ID="HGNC:4180" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="81489703" stop="81761645" display_start="81489703" display_stop="81761645" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="81538849" stop="81810949" display_start="81538849" display_stop="81810949" Strand="-" />
          </Location>
          <OMIM>607839</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000158.4(GBE1):c.216del (p.Tyr73fs)</Name>
      <CanonicalSPDI>NC_000003.12:81705540:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="81705541" stop="81705541" display_start="81705541" display_stop="81705541" variantLength="1" positionVCF="81705540" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="81754692" stop="81754692" display_start="81754692" display_stop="81754692" variantLength="1" positionVCF="81754691" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>Y73fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.81754692del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.81754692del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.81705541del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.81705541del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011810.1" sequenceAccession="NG_011810" sequenceVersion="1" change="g.61260del">
            <Expression>NG_011810.1:g.61260del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000158.4" sequenceAccession="NM_000158" sequenceVersion="4" change="c.216del" MANESelect="true">
            <Expression>NM_000158.4:c.216del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000149.4" sequenceAccession="NP_000149" sequenceVersion="4" change="p.Tyr73fs">
            <Expression>NP_000149.4:p.Tyr73fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000158.3" sequenceAccession="NM_000158" sequenceVersion="3" change="c.216delC">
            <Expression>NM_000158.3:c.216delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2107168870" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000158.4(GBE1):c.216del (p.Tyr73fs) AND multiple conditions" Accession="RCV001384176" Version="3">
        <ClassifiedConditionList TraitSetID="39830">
          <ClassifiedCondition DB="MedGen" ID="C1856301">Glycogen storage disease IV, classic hepatic</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0017923">Glycogen storage disease, type IV</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-08-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000158.4(GBE1):c.216del (p.Tyr73fs) AND GBE1-related disorder" Accession="RCV004528497" Version="1">
        <ClassifiedConditionList TraitSetID="33700">
          <ClassifiedCondition DB="MedGen" ID="CN239402">GBE1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000158.4(GBE1):c.216del (p.Tyr73fs) AND Glycogen storage disease, type IV" Accession="RCV004570952" Version="1">
        <ClassifiedConditionList TraitSetID="6269">
          <ClassifiedCondition DB="MedGen" ID="C0017923">Glycogen storage disease, type IV</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-28" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-28" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-05-10" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15452297</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20058079</ID>
        </Citation>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="39830" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9280" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD IV, CLASSIC HEPATIC</ElementValue>
                <XRef ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IV, classic hepatic</ElementValue>
              </Name>
              <XRef ID="C1856301" DB="MedGen" />
            </Trait>
            <Trait ID="5200" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Brancher deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amylopectinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen branching enzyme deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cirrhosis, familial, with deposition of abnormal glycogen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GBE1 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOGENOSIS IV</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IV</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type IV</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+4/3124" DB="Genetic Alliance" />
                <XRef ID="11179002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease due to glycogen branching enzyme deficiency</ElementValue>
                <XRef ID="MONDO:0009292" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD4</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of glycogen storage disease type IV (GSD IV) discussed in this entry span a continuum of different subtypes with variable ages of onset, severity, and clinical features. Clinical findings vary extensively both within and between families. The fatal perinatal neuromuscular subtype presents in utero with fetal akinesia deformation sequence, including decreased fetal movements, polyhydramnios, and fetal hydrops. Death usually occurs in the neonatal period. The congenital neuromuscular subtype presents in the newborn period with profound hypotonia, respiratory distress, and dilated cardiomyopathy. Death usually occurs in early infancy. Infants with the classic (progressive) hepatic subtype may appear normal at birth, but rapidly develop failure to thrive; hepatomegaly, liver dysfunction, and progressive liver cirrhosis; hypotonia; and cardiomyopathy. Without liver transplantation, death from liver failure usually occurs by age five years. Children with the non-progressive hepatic subtype tend to present with hepatomegaly, liver dysfunction, myopathy, and hypotonia; however, they are likely to survive without progression of the liver disease and may not show cardiac, skeletal muscle, or neurologic involvement. The childhood neuromuscular subtype is rare and the course is variable, ranging from onset in the second decade with a mild disease course to a more severe, progressive course resulting in death in the third decade.</Attribute>
                <XRef ID="NBK115333" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2520" />
                <XRef ID="2520" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23285490</ID>
                <ID Source="BookShelf">NBK115333</ID>
              </Citation>
              <XRef ID="367" DB="Orphanet" />
              <XRef ID="C0017923" DB="MedGen" />
              <XRef ID="MONDO:0009292" DB="MONDO" />
              <XRef Type="MIM" ID="232500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33700" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36599" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GBE1-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GBE1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GBE1-related disorder</ElementValue>
              </Name>
              <XRef ID="CN239402" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6269" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5200" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Brancher deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amylopectinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen branching enzyme deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cirrhosis, familial, with deposition of abnormal glycogen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GBE1 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOGENOSIS IV</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IV</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type IV</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+4/3124" DB="Genetic Alliance" />
                <XRef ID="11179002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease due to glycogen branching enzyme deficiency</ElementValue>
                <XRef ID="MONDO:0009292" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD4</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of glycogen storage disease type IV (GSD IV) discussed in this entry span a continuum of different subtypes with variable ages of onset, severity, and clinical features. Clinical findings vary extensively both within and between families. The fatal perinatal neuromuscular subtype presents in utero with fetal akinesia deformation sequence, including decreased fetal movements, polyhydramnios, and fetal hydrops. Death usually occurs in the neonatal period. The congenital neuromuscular subtype presents in the newborn period with profound hypotonia, respiratory distress, and dilated cardiomyopathy. Death usually occurs in early infancy. Infants with the classic (progressive) hepatic subtype may appear normal at birth, but rapidly develop failure to thrive; hepatomegaly, liver dysfunction, and progressive liver cirrhosis; hypotonia; and cardiomyopathy. Without liver transplantation, death from liver failure usually occurs by age five years. Children with the non-progressive hepatic subtype tend to present with hepatomegaly, liver dysfunction, myopathy, and hypotonia; however, they are likely to survive without progression of the liver disease and may not show cardiac, skeletal muscle, or neurologic involvement. The childhood neuromuscular subtype is rare and the course is variable, ranging from onset in the second decade with a mild disease course to a more severe, progressive course resulting in death in the third decade.</Attribute>
                <XRef ID="NBK115333" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2520" />
                <XRef ID="2520" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23285490</ID>
                <ID Source="BookShelf">NBK115333</ID>
              </Citation>
              <XRef ID="367" DB="Orphanet" />
              <XRef ID="C0017923" DB="MedGen" />
              <XRef ID="MONDO:0009292" DB="MONDO" />
              <XRef Type="MIM" ID="232500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7683266" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="20152701|GBE1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004108542" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The GBE1 c.216delC variant is predicted to result in a frameshift and premature protein termination (p.Tyr73Metfs*70). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in GBE1 are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GBE1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000158.3:c.216delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GBE1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3109203" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11674507|MedGen:C0017923;C1856301" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001583563" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15452297</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20058079</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in GBE1 are known to be pathogenic (PMID: 15452297, 20058079). This variant has not been reported in the literature in individuals with GBE1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Tyr73Metfs*70) in the GBE1 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GBE1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.81754692del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017923" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1856301" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9818992" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000158.4:c.216del|OMIM:232500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005058918" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000158.4:c.216del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3109203" TraitType="Disease" MappingType="XRef" MappingValue="C0017923" MappingRef="MedGen">
        <MedGen CUI="C0017923" Name="Glycogen storage disease, type IV" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3109203" TraitType="Disease" MappingType="XRef" MappingValue="C1856301" MappingRef="MedGen">
        <MedGen CUI="C1856301" Name="Glycogen storage disease IV, classic hepatic" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9818992" TraitType="Disease" MappingType="XRef" MappingValue="232500" MappingRef="OMIM">
        <MedGen CUI="C0017923" Name="Glycogen storage disease, type IV" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7683266" TraitType="Disease" MappingType="Name" MappingValue="GBE1-related condition" MappingRef="Preferred">
        <MedGen CUI="CN239402" Name="GBE1-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

